Van Waalwijk van Doorn et al_WMH_JAD_accepted manuscript - White matter hyperintensities ....pdf (1.03 MB)
White matter hyperintensities are no major confounder for alzheimer's disease cerebrospinal fluid biomarkers
journal contribution
posted on 2023-06-09, 22:27 authored by Linda J C van Waalwijk van Doorn, Mohsen Ghafoorian, Esther M C van Leijsen, Jurgen A H R Claassen, Andrea Arighi, Marco Bozzali, Jorge Cannas, Enrica Cavedo, Paolo Eusebi, Lucia Farotti, Chiara Fenoglio, Juan Fortea, Giovanni B Frisoni, Daniela Galimberti, Viviana Greco, othersBackground: The cerebrospinal fluid (CSF) biomarkers amyloid-ß 1–42 (Aß 42), total and phosphorylated tau (t-tau, p-tau) are increasingly used to assist in the clinical diagnosis of Alzheimer’s disease (AD). However, CSF biomarker levels can be affected by confounding factors. Objective: To investigate the association of white matter hyperintensities (WMHs) present in the brain with AD CSF biomarker levels. Methods: We included CSF biomarker and magnetic resonance imaging (MRI) data of 172 subjects (52 controls, 72 mild cognitive impairment (MCI), and 48 AD patients) from 9 European Memory Clinics. A computer aided detection system for standardized automated segmentation of WMHs was used on MRI scans to determine WMH volumes. Association of WMH volume with AD CSF biomarkers was determined using linear regression analysis. Results: A small, negative association of CSF Aß 42, but not p-tau and t-tau, levels with WMH volume was observed in the AD (r 2?=?0.084, p?=?0.046), but not the MCI and control groups, which was slightly increased when including the distance of WMHs to the ventricles in the analysis (r 2?=?0.105, p?=?0.025). Three global patterns of WMH distribution, either with 1) a low, 2) a peak close to the ventricles, or 3) a high, broadly-distributed WMH volume could be observed in brains of subjects in each diagnostic group. Conclusion: Despite an association of WMH volume with CSF Aß 42 levels in AD patients, the occurrence of WMHs is not accompanied by excess release of cellular proteins in the CSF, suggesting that WMHs are no major confounder for AD CSF biomarker assessment.
History
Publication status
- Published
File Version
- Accepted version
Journal
Journal of Alzheimer's DiseaseISSN
1387-2877Publisher
IOS PressExternal DOI
Page range
1-13Event location
NetherlandsDepartment affiliated with
- BSMS Neuroscience Publications
Full text available
- Yes
Peer reviewed?
- Yes
Legacy Posted Date
2020-12-15First Open Access (FOA) Date
2020-12-15First Compliant Deposit (FCD) Date
2020-12-15Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC